{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:43:30Z","timestamp":1788903810379,"version":"build-2803163510"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"MSH Medical School Hamburg - University of Applied Sciences and Medical University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Gliomas are tumours arising mostly from astrocytic or oligodendrocytic precursor cells. These tumours are classified according to the updated WHO classification from 2021 in 4 grades depending on molecular and histopathological criteria. Despite novel multimodal therapeutic approaches, the vast majority of gliomas (WHO grade III and IV) are not curable. The circadian clock is an important regulator of numerous cellular processes and its dysregulation had been found during the progression of many cancers, including gliomas.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In this study, we explore expression patterns of clock-controlled genes in low-grade glioma (LGG) and glioblastoma multiforme (GBM) and show that a set of 45 clock-controlled genes can be used to distinguish GBM from normal tissue. Subsequent analysis identified 17 clock-controlled genes with a significant association with survival. The results point to a loss of correlation strength within elements of the circadian clock network in GBM compared to LGG. We further explored the progression patterns of mutations in LGG and GBM, and showed that tumour suppressor <jats:italic>APC<\/jats:italic> is lost late both in LGG and GBM. Moreover, <jats:italic>HIF1A<\/jats:italic>, involved in cellular response to hypoxia, exhibits subclonal losses in LGG, and <jats:italic>TERT<\/jats:italic>, involved in the formation of telomerase, is lost late in the GBM progression. By examining multi-sample LGG data, we find that the clock-controlled driver genes <jats:italic>APC<\/jats:italic>, <jats:italic>HIF1A<\/jats:italic>, <jats:italic>TERT<\/jats:italic> and <jats:italic>TP53<\/jats:italic> experience frequent subclonal gains and losses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our results show a higher level of disrgulation at the gene expression level in GBM compared to LGG, and indicate an association between the differentially expressed clock-regulated genes and patient survival in both LGG and GBM. By reconstructing the patterns of progression in LGG and GBM, our data reveals the relatively late gains and losses of clock-regulated glioma drivers. Our analysis emphasizes the role of clock-regulated genes in glioma development and progression. Yet, further research is needed to asses their value in the development of new treatments.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12920-023-01585-w","type":"journal-article","created":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T10:02:39Z","timestamp":1688378559000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Differential expression of the circadian clock network correlates with tumour progression in gliomas"],"prefix":"10.1186","volume":"16","author":[{"given":"Marina","family":"Petkovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00fcge","family":"Yal\u00e7in","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Heese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Rel\u00f3gio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,3]]},"reference":[{"issue":"8","key":"1585_CR1","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, et al. The 2021 WHO classification of tumors of the Central Nervous System: a summary. Neuro Oncol. 2021;23(8):1231\u201351.","journal-title":"Neuro Oncol"},{"issue":"1","key":"1585_CR2","doi-asserted-by":"publisher","first-page":"15017","DOI":"10.1038\/nrdp.2015.17","volume":"1","author":"M Weller","year":"2015","unstructured":"Weller M, Wick W, Aldape K, Brada M, Berger M, Pfister SM, Nishikawa R, Rosenthal M, Wen PY, Stupp R, et al. Glioma. Nat Rev Dis Primers. 2015;1(1):15017.","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"1585_CR3","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.soncn.2018.10.001","volume":"34","author":"ME Davis","year":"2018","unstructured":"Davis ME. Epidemiology and overview of Gliomas. Semin Oncol Nurs. 2018;34(5):420\u20139.","journal-title":"Semin Oncol Nurs"},{"issue":"7","key":"1585_CR4","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/neuonc\/nou087","volume":"16","author":"QT Ostrom","year":"2014","unstructured":"Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh KM, et al. The epidemiology of glioma in adults: a \u201cstate of the science\u201d review. Neuro Oncol. 2014;16(7):896\u2013913.","journal-title":"Neuro Oncol"},{"issue":"2","key":"1585_CR5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.cell.2011.06.014","volume":"146","author":"C Liu","year":"2011","unstructured":"Liu C, Sage JC, Miller MR, Verhaak RG, Hippenmeyer S, Vogel H, Foreman O, Bronson RT, Nishiyama A, Luo L, et al. Mosaic analysis with double markers reveals tumor cell of origin in glioma. Cell. 2011;146(2):209\u201321.","journal-title":"Cell"},{"issue":"7717","key":"1585_CR6","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41586-018-0389-3","volume":"560","author":"JH Lee","year":"2018","unstructured":"Lee JH, Lee JE, Kahng JY, Kim SH, Park JS, Yoon SJ, Um JY, Kim WK, Lee JK, Park J, et al. Human glioblastoma arises from subventricular zone cells with low-level driver mutations. Nature. 2018;560(7717):243\u20137.","journal-title":"Nature"},{"issue":"2","key":"1585_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"DN Louis","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97\u2013109.","journal-title":"Acta Neuropathol"},{"issue":"Suppl 5","key":"1585_CR8","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noz150","volume":"21","author":"QT Ostrom","year":"2019","unstructured":"Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS Statistical Report: primary brain and other Central Nervous System Tumors diagnosed in the United States in 2012\u20132016. Neuro Oncol. 2019;21(Suppl 5):v1\u2013v100.","journal-title":"Neuro Oncol"},{"issue":"11","key":"1585_CR9","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1038\/ng.926","volume":"43","author":"SN Stacey","year":"2011","unstructured":"Stacey SN, Sulem P, Jonasdottir A, Masson G, Gudmundsson J, Gudbjartsson DF, Magnusson OT, Gudjonsson SA, Sigurgeirsson B, Thorisdottir K, et al. A germline variant in the TP53 polyadenylation signal confers cancer susceptibility. Nat Genet. 2011;43(11):1098\u2013103.","journal-title":"Nat Genet"},{"key":"1585_CR10","doi-asserted-by":"crossref","unstructured":"Zhang Y, Dube C, Gibert M Jr, Cruickshanks N, Wang B, Coughlan M, Yang Y, Setiady I, Deveau C, Saoud K et al. The p53 pathway in Glioblastoma. Cancers (Basel) 2018, 10(9).","DOI":"10.3390\/cancers10090297"},{"issue":"12","key":"1585_CR11","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1007\/s00439-012-1212-0","volume":"131","author":"P Rajaraman","year":"2012","unstructured":"Rajaraman P, Melin BS, Wang Z, McKean-Cowdin R, Michaud DS, Wang SS, Bondy M, Houlston R, Jenkins RB, Wrensch M, et al. Genome-wide association study of glioma and meta-analysis. Hum Genet. 2012;131(12):1877\u201388.","journal-title":"Hum Genet"},{"issue":"8","key":"1585_CR12","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/ng.407","volume":"41","author":"S Shete","year":"2009","unstructured":"Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malmer B, Simon M, Marie Y, Boisselier B, Delattre JY, et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet. 2009;41(8):899\u2013904.","journal-title":"Nat Genet"},{"issue":"3","key":"1585_CR13","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ccr.2014.02.025","volume":"25","author":"CL Arteaga","year":"2014","unstructured":"Arteaga CL, Engelman JA. ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics. Cancer Cell. 2014;25(3):282\u2013303.","journal-title":"Cancer Cell"},{"issue":"6","key":"1585_CR14","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3109\/0284186X.2010.480980","volume":"49","author":"U Andersson","year":"2010","unstructured":"Andersson U, Schwartzbaum J, Wiklund F, Sjostrom S, Liu Y, Tsavachidis S, Ahlbom A, Auvinen A, Collatz-Laier H, Feychting M, et al. A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk. Acta Oncol. 2010;49(6):767\u201375.","journal-title":"Acta Oncol"},{"issue":"10","key":"1585_CR15","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/ng.2388","volume":"44","author":"RB Jenkins","year":"2012","unstructured":"Jenkins RB, Xiao Y, Sicotte H, Decker PA, Kollmeyer TM, Hansen HM, Kosel ML, Zheng S, Walsh KM, Rice T, et al. A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation. Nat Genet. 2012;44(10):1122\u20135.","journal-title":"Nat Genet"},{"issue":"5","key":"1585_CR16","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/neuonc\/nos324","volume":"15","author":"T Rice","year":"2013","unstructured":"Rice T, Zheng S, Decker PA, Walsh KM, Bracci P, Xiao Y, McCoy LS, Smirnov I, Patoka JS, Hansen HM, et al. Inherited variant on chromosome 11q23 increases susceptibility to IDH-mutated but not IDH-normal gliomas regardless of grade or histology. Neuro Oncol. 2013;15(5):535\u201341.","journal-title":"Neuro Oncol"},{"issue":"3","key":"1585_CR17","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s11060-019-03250-8","volume":"144","author":"Y Fukuya","year":"2019","unstructured":"Fukuya Y, Ikuta S, Maruyama T, Nitta M, Saito T, Tsuzuki S, Chernov M, Kawamata T, Muragaki Y. Tumor recurrence patterns after surgical resection of intracranial low-grade gliomas. J Neurooncol. 2019;144(3):519\u201328.","journal-title":"J Neurooncol"},{"key":"1585_CR18","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.wneu.2017.08.136","volume":"108","author":"AA Kumar","year":"2017","unstructured":"Kumar AA, Abraham Koshy A. Regression of recurrent High-Grade Glioma with Temozolomide, Dexamethasone, and Levetiracetam: Case Report and Review of the literature. World Neurosurg. 2017;108:990. e911-990 e916.","journal-title":"World Neurosurg"},{"issue":"4","key":"1585_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41582-022-00621-0","volume":"18","author":"TS van Solinge","year":"2022","unstructured":"van Solinge TS, Nieland L, Chiocca EA, Broekman MLD. Advances in local therapy for glioblastoma - taking the fight to the tumour. Nat Rev Neurol. 2022;18(4):221\u201336.","journal-title":"Nat Rev Neurol"},{"issue":"11","key":"1585_CR20","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1158\/2159-8290.CD-19-0215","volume":"9","author":"Z Dong","year":"2019","unstructured":"Dong Z, Zhang G, Qu M, Gimple RC, Wu Q, Qiu Z, Prager BC, Wang X, Kim LJY, Morton AR, et al. Targeting glioblastoma stem cells through disruption of the circadian clock. Cancer Discov. 2019;9(11):1556\u201373.","journal-title":"Cancer Discov"},{"key":"1585_CR21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3389\/fonc.2020.00199","volume":"10","author":"K Arafa","year":"2020","unstructured":"Arafa K, Emara M. Insights about Circadian Clock and Molecular Pathogenesis in Gliomas. Front Oncol. 2020;10:199.","journal-title":"Front Oncol"},{"issue":"8","key":"1585_CR22","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/ncpneuro0847","volume":"4","author":"SR Pandi-Perumal","year":"2008","unstructured":"Pandi-Perumal SR, Trakht I, Spence DW, Srinivasan V, Dagan Y, Cardinali DP. The roles of melatonin and light in the pathophysiology and treatment of circadian rhythm sleep disorders. Nat Clin Pract Neurol. 2008;4(8):436\u201347.","journal-title":"Nat Clin Pract Neurol"},{"issue":"4","key":"1585_CR23","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.ncl.2012.08.011","volume":"30","author":"L Zhu","year":"2012","unstructured":"Zhu L, Zee PC. Circadian rhythm sleep disorders. Neurol Clin. 2012;30(4):1167\u201391.","journal-title":"Neurol Clin"},{"key":"1585_CR24","doi-asserted-by":"publisher","first-page":"103080","DOI":"10.1016\/j.ebiom.2020.103080","volume":"62","author":"M Akashi","year":"2020","unstructured":"Akashi M, Sogawa R, Matsumura R, Nishida A, Nakamura R, Tokuda IT, Node K. A detection method for latent circadian rhythm sleep-wake disorder. EBioMedicine. 2020;62:103080.","journal-title":"EBioMedicine"},{"key":"1585_CR25","doi-asserted-by":"publisher","first-page":"873237","DOI":"10.3389\/fphys.2022.873237","volume":"13","author":"M Yalcin","year":"2022","unstructured":"Yalcin M, Mundorf A, Thiel F, Amatriain-Fernandez S, Kalthoff IS, Beucke JC, Budde H, Garthus-Niegel S, Peterburs J, Relogio A. It\u2019s about time: the Circadian Network as Time-Keeper for cognitive functioning, locomotor activity and Mental Health. Front Physiol. 2022;13:873237.","journal-title":"Front Physiol"},{"issue":"1","key":"1585_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41398-020-0694-0","volume":"10","author":"WH Walker","year":"2020","unstructured":"Walker WH 2nd, Walton JC, DeVries AC, Nelson RJ. Circadian rhythm disruption and mental health. Transl Psychiatry. 2020;10(1):28.","journal-title":"Transl Psychiatry"},{"key":"1585_CR27","doi-asserted-by":"publisher","first-page":"644747","DOI":"10.3389\/fmolb.2021.644747","volume":"8","author":"B Carter","year":"2021","unstructured":"Carter B, Justin HS, Gulick D, Gamsby JJ. The Molecular Clock and neurodegenerative disease: a stressful time. Front Mol Biosci. 2021;8:644747.","journal-title":"Front Mol Biosci"},{"key":"1585_CR28","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fnagi.2017.00170","volume":"9","author":"S Hood","year":"2017","unstructured":"Hood S, Amir S. Neurodegeneration and the circadian clock. Front Aging Neurosci. 2017;9:170.","journal-title":"Front Aging Neurosci"},{"key":"1585_CR29","doi-asserted-by":"crossref","unstructured":"Yalcin M, Malhan D, Basti A, Peralta AR, Ferreira JJ, Relogio A. A Computational Analysis in a Cohort of Parkinson\u2019s Disease Patients and Clock-Modified Colorectal Cancer Cells Reveals Common Expression Alterations in Clock-Regulated Genes. Cancers (Basel) 2021, 13(23).","DOI":"10.3390\/cancers13235978"},{"key":"1585_CR30","doi-asserted-by":"crossref","unstructured":"Mure LS, Le HD, Benegiamo G, Chang MW, Rios L, Jillani N, Ngotho M, Kariuki T, Dkhissi-Benyahya O, Cooper HM et al. Diurnal transcriptome atlas of a primate across major neural and peripheral tissues. Science 2018, 359(6381).","DOI":"10.1126\/science.aao0318"},{"issue":"45","key":"1585_CR31","doi-asserted-by":"publisher","first-page":"16219","DOI":"10.1073\/pnas.1408886111","volume":"111","author":"R Zhang","year":"2014","unstructured":"Zhang R, Lahens NF, Ballance HI, Hughes ME, Hogenesch JB. A circadian gene expression atlas in mammals: implications for biology and medicine. Proc Natl Acad Sci U S A. 2014;111(45):16219\u201324.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1585_CR32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1152\/physrev.00016.2012","volume":"93","author":"K Eckel-Mahan","year":"2013","unstructured":"Eckel-Mahan K, Sassone-Corsi P. Metabolism and the circadian clock converge. Physiol Rev. 2013;93(1):107\u201335.","journal-title":"Physiol Rev"},{"key":"1585_CR33","doi-asserted-by":"crossref","unstructured":"Fuhr L, El-Athman R, Scrima R, Cela O, Carbone A, Knoop H, Li Y, Hoffmann K, Laukkanen MO, Corcione F et al. The Circadian Clock Regulates Metabolic Phenotype Rewiring Via HKDC1 and Modulates Tumor Progression and Drug Response in Colorectal Cancer. EBioMedicine 2018, 33:105\u2013121.","DOI":"10.1016\/j.ebiom.2018.07.002"},{"key":"1585_CR34","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ebiom.2018.06.012","volume":"33","author":"R El-Athman","year":"2018","unstructured":"El-Athman R, Fuhr L, Relogio A. A Systems-Level Analysis reveals circadian regulation of splicing in Colorectal Cancer. EBioMedicine. 2018;33:68\u201381.","journal-title":"EBioMedicine"},{"issue":"1","key":"1585_CR35","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41540-022-00225-w","volume":"8","author":"D Malhan","year":"2022","unstructured":"Malhan D, Basti A, Relogio A. Transcriptome analysis of clock disrupted cancer cells reveals differential alternative splicing of cancer hallmarks genes. NPJ Syst Biol Appl. 2022;8(1):17.","journal-title":"NPJ Syst Biol Appl"},{"issue":"12","key":"1585_CR36","doi-asserted-by":"publisher","first-page":"e2002940","DOI":"10.1371\/journal.pbio.2002940","volume":"15","author":"R El-Athman","year":"2017","unstructured":"El-Athman R, Genov NN, Mazuch J, Zhang K, Yu Y, Fuhr L, Abreu M, Li Y, Wallach T, Kramer A, et al. The Ink4a\/Arf locus operates as a regulator of the circadian clock modulating RAS activity. PLoS Biol. 2017;15(12):e2002940.","journal-title":"PLoS Biol"},{"key":"1585_CR37","doi-asserted-by":"crossref","unstructured":"Li Y, Basti A, Yalcin M, Relogio A. Circadian Dysregulation of the TGFbeta\/SMAD4 Pathway Modulates Metastatic Properties and Cell Fate Decisions in Pancreatic Cancer Cells. iScience 2020, 23(10):101551.","DOI":"10.1016\/j.isci.2020.101551"},{"key":"1585_CR38","doi-asserted-by":"crossref","unstructured":"Basti A, Fior R, Yalin M, Povoa V, Astaburuaga R, Li Y, Naderi J, Godinho Ferreira M, Relogio A. The core-clock gene NR1D1 impacts cell motility in Vitro and Invasiveness in a zebrafish xenograft Colon Cancer Model. Cancers (Basel) 2020, 12(4).","DOI":"10.3390\/cancers12040853"},{"issue":"3","key":"1585_CR39","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/nri3386","volume":"13","author":"C Scheiermann","year":"2013","unstructured":"Scheiermann C, Kunisaki Y, Frenette PS. Circadian control of the immune system. Nat Rev Immunol. 2013;13(3):190\u20138.","journal-title":"Nat Rev Immunol"},{"key":"1585_CR40","doi-asserted-by":"crossref","unstructured":"Ko CH, Takahashi JS. Molecular components of the mammalian circadian clock. Hum Mol Genet 2006, 15 Spec No 2(suppl_2):R271-277.","DOI":"10.1093\/hmg\/ddl207"},{"issue":"5","key":"1585_CR41","doi-asserted-by":"publisher","first-page":"e0126283","DOI":"10.1371\/journal.pone.0126283","volume":"10","author":"R Lehmann","year":"2015","unstructured":"Lehmann R, Childs L, Thomas P, Abreu M, Fuhr L, Herzel H, Leser U, Relogio A. Assembly of a comprehensive regulatory network for the mammalian circadian clock: a bioinformatics approach. PLoS ONE. 2015;10(5):e0126283.","journal-title":"PLoS ONE"},{"issue":"1","key":"1585_CR42","doi-asserted-by":"publisher","first-page":"91","DOI":"10.7785\/tcrt.2012.500250","volume":"12","author":"Z Chen","year":"2013","unstructured":"Chen Z, Liu P, Li C, Luo Y, Chen I, Liang W, Chen X, Feng Y, Xia H, Wang F. Deregulated expression of the clock genes in gliomas. Technol Cancer Res Treat. 2013;12(1):91\u20137.","journal-title":"Technol Cancer Res Treat"},{"issue":"1","key":"1585_CR43","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10552-013-0305-y","volume":"25","author":"MH Madden","year":"2014","unstructured":"Madden MH, Anic GM, Thompson RC, Nabors LB, Olson JJ, Browning JE, Monteiro AN, Egan KM. Circadian pathway genes in relation to glioma risk and outcome. Cancer Causes Control. 2014;25(1):25\u201332.","journal-title":"Cancer Causes Control"},{"issue":"6","key":"1585_CR44","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.3892\/or.2013.2381","volume":"29","author":"CH Jung","year":"2013","unstructured":"Jung CH, Kim EM, Park JK, Hwang SG, Moon SK, Kim WJ, Um HD. Bmal1 suppresses cancer cell invasion by blocking the phosphoinositide 3-kinase-Akt-MMP-2 signaling pathway. Oncol Rep. 2013;29(6):2109\u201313.","journal-title":"Oncol Rep"},{"issue":"3","key":"1585_CR45","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1017\/S031716710001026X","volume":"37","author":"HC Xia","year":"2010","unstructured":"Xia HC, Niu ZF, Ma H, Cao SZ, Hao SC, Liu ZT, Wang F. Deregulated expression of the Per1 and Per2 in human gliomas. Can J Neurol Sci. 2010;37(3):365\u201370.","journal-title":"Can J Neurol Sci"},{"issue":"11","key":"1585_CR46","doi-asserted-by":"publisher","first-page":"5725","DOI":"10.7314\/APJCP.2012.13.11.5725","volume":"13","author":"Y Luo","year":"2012","unstructured":"Luo Y, Wang F, Chen LA, Chen XW, Chen ZJ, Liu PF, li FF, Li CY, Liang W. Deregulated expression of cry1 and cry2 in human gliomas. Asian Pac J Cancer Prev. 2012;13(11):5725\u20138.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1585_CR47","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3389\/fphar.2016.00139","volume":"7","author":"G Maugeri","year":"2016","unstructured":"Maugeri G, D\u2019Amico AG, Reitano R, Magro G, Cavallaro S, Salomone S, D\u2019Agata V. PACAP and VIP inhibit the invasiveness of Glioblastoma cells exposed to Hypoxia through the regulation of HIFs and EGFR expression. Front Pharmacol. 2016;7:139.","journal-title":"Front Pharmacol"},{"issue":"8","key":"1585_CR48","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico A, Silva TC, Olsen C, Garofano L, Cava C, Garolini D, Sabedot TS, Malta TM, Pagnotta SM, Castiglioni I, et al. TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 2016;44(8):e71.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"1585_CR49","doi-asserted-by":"publisher","first-page":"e1006701","DOI":"10.1371\/journal.pcbi.1006701","volume":"15","author":"M Mounir","year":"2019","unstructured":"Mounir M, Lucchetta M, Silva TC, Olsen C, Bontempi G, Chen X, Noushmehr H, Colaprico A, Papaleo E. New functionalities in the TCGAbiolinks package for the study and integration of cancer data from GDC and GTEx. PLoS Comput Biol. 2019;15(3):e1006701.","journal-title":"PLoS Comput Biol"},{"issue":"5","key":"1585_CR50","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/ng.3273","volume":"47","author":"H Suzuki","year":"2015","unstructured":"Suzuki H, Aoki K, Chiba K, Sato Y, Shiozawa Y, Shiraishi Y, Shimamura T, Niida A, Motomura K, Ohka F, et al. Mutational landscape and clonal architecture in grade II and III gliomas. Nat Genet. 2015;47(5):458\u201368.","journal-title":"Nat Genet"},{"issue":"7","key":"1585_CR51","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1585_CR52","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139\u201340.","journal-title":"Bioinformatics"},{"issue":"W1","key":"1585_CR53","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47(W1):W556\u201360.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"1585_CR54","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.trecan.2019.07.002","volume":"5","author":"G Sulli","year":"2019","unstructured":"Sulli G, Lam MTY, Panda S. Interplay between Circadian Clock and Cancer: New Frontiers for Cancer Treatment. Trends Cancer. 2019;5(8):475\u201394.","journal-title":"Trends Cancer"},{"key":"1585_CR55","unstructured":"A Package for Survival Analysis. in R [https:\/\/CRAN.R-project.org\/package=survival. ]."},{"issue":"3","key":"1585_CR56","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, Feng T, Zhou L, Tang W, Zhan L, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innov (Camb). 2021;2(3):100141.","journal-title":"Innov (Camb)"},{"issue":"5","key":"1585_CR57","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"issue":"18","key":"1585_CR58","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1093\/bioinformatics\/btv296","volume":"31","author":"D Ramazzotti","year":"2015","unstructured":"Ramazzotti D, Caravagna G, Olde Loohuis L, Graudenzi A, Korsunsky I, Mauri G, Antoniotti M, Mishra B. CAPRI: efficient inference of cancer progression models from cross-sectional data. Bioinformatics. 2015;31(18):3016\u201326.","journal-title":"Bioinformatics"},{"issue":"D1","key":"1585_CR59","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2019","unstructured":"Tate JG, Bamford S, Jubb HC, Sondka Z, Beare DM, Bindal N, Boutselakis H, Cole CG, Creatore C, Dawson E, et al. COSMIC: the catalogue of somatic mutations in Cancer. Nucleic Acids Res. 2019;47(D1):D941\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"16","key":"1585_CR60","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R. Genome Project Data Processing S: the sequence Alignment\/Map format and SAMtools. Bioinformatics. 2009;25(16):2078\u20139.","journal-title":"Bioinformatics"},{"issue":"1","key":"1585_CR61","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/annonc\/mdu479","volume":"26","author":"F Favero","year":"2015","unstructured":"Favero F, Joshi T, Marquard AM, Birkbak NJ, Krzystanek M, Li Q, Szallasi Z, Eklund AC. Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data. Ann Oncol. 2015;26(1):64\u201370.","journal-title":"Ann Oncol"},{"key":"1585_CR62","doi-asserted-by":"crossref","unstructured":"Kaufmann TLP, Watkins M, Colliver TBK, Laskina EC, Thapa S, Minussi N, Navin DC, Swanton N, Van Loo C, Haase P, Tarabichi K. Maxime; Schwarz, Roland F: MEDICC2: whole-genome doubling aware copy-number phylogenies for cancer evolution. bioRxiv 2021.","DOI":"10.1101\/2021.02.28.433227"},{"issue":"3","key":"1585_CR63","doi-asserted-by":"publisher","first-page":"260","DOI":"10.21037\/atm-20-3219","volume":"9","author":"J Liu","year":"2021","unstructured":"Liu J, Gao L, Liao J, Yang J, Yuan F, Chen Q. Kiaa0101 serves as a prognostic marker and promotes invasion by regulating p38\/snail1 pathway in glioma. Ann Transl Med. 2021;9(3):260.","journal-title":"Ann Transl Med"},{"issue":"2","key":"1585_CR64","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s11011-021-00863-9","volume":"37","author":"K Wang","year":"2022","unstructured":"Wang K, Li J, Zhou B. KIAA0101 knockdown inhibits glioma progression and glycolysis by inactivating the PI3K\/AKT\/mTOR pathway. Metab Brain Dis. 2022;37(2):489\u201399.","journal-title":"Metab Brain Dis"},{"issue":"18","key":"1585_CR65","doi-asserted-by":"publisher","first-page":"7650","DOI":"10.1158\/0008-5472.CAN-08-1137","volume":"68","author":"D Zheng","year":"2008","unstructured":"Zheng D, Cho YY, Lau AT, Zhang J, Ma WY, Bode AM, Dong Z. Cyclin-dependent kinase 3-mediated activating transcription factor 1 phosphorylation enhances cell transformation. Cancer Res. 2008;68(18):7650\u201360.","journal-title":"Cancer Res"},{"issue":"1","key":"1585_CR66","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/bjc.1992.225","volume":"66","author":"JM Orian","year":"1992","unstructured":"Orian JM, Vasilopoulos K, Yoshida S, Kaye AH, Chow CW, Gonzales MF. Overexpression of multiple oncogenes related to histological grade of astrocytic glioma. Br J Cancer. 1992;66(1):106\u201312.","journal-title":"Br J Cancer"},{"key":"1585_CR67","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.biopha.2016.08.004","volume":"83","author":"S Chen","year":"2016","unstructured":"Chen S, Wang Y, Ni C, Meng G, Sheng X. HLF\/miR-132\/TTK axis regulates cell proliferation, metastasis and radiosensitivity of glioma cells. Biomed Pharmacother. 2016;83:898\u2013904.","journal-title":"Biomed Pharmacother"},{"issue":"19","key":"1585_CR68","doi-asserted-by":"publisher","first-page":"4875","DOI":"10.1158\/0008-5472.CAN-12-2217","volume":"72","author":"C Swanton","year":"2012","unstructured":"Swanton C. Intratumor heterogeneity: evolution through space and time. Cancer Res. 2012;72(19):4875\u201382.","journal-title":"Cancer Res"},{"key":"1585_CR69","doi-asserted-by":"crossref","unstructured":"Weller M, Wick W, Aldape K, Brada M, Berger M, Pfister SM, Nishikawa R, Rosenthal M, Wen PY, Stupp R et al. Glioma. Nature Reviews Disease Primers 2015, 1(1):15017.","DOI":"10.1038\/nrdp.2015.17"},{"issue":"3","key":"1585_CR70","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/35106065","volume":"1","author":"M Malumbres","year":"2001","unstructured":"Malumbres M, Barbacid M. To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer. 2001;1(3):222\u201331.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"1585_CR71","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/S0090-3019(98)00028-7","volume":"51","author":"JW Herms","year":"1999","unstructured":"Herms JW, von Loewenich FD, Behnke J, Markakis E, Kretzschmar HA. c-myc oncogene family expression in glioblastoma and survival. Surg Neurol. 1999;51(5):536\u201342.","journal-title":"Surg Neurol"},{"issue":"5643","key":"1585_CR72","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1126\/science.1086271","volume":"302","author":"T Matsuo","year":"2003","unstructured":"Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H. Control mechanism of the circadian clock for timing of cell division in vivo. Science. 2003;302(5643):255\u20139.","journal-title":"Science"},{"issue":"1","key":"1585_CR73","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0092-8674(02)00961-3","volume":"111","author":"L Fu","year":"2002","unstructured":"Fu L, Pelicano H, Liu J, Huang P, Lee C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell. 2002;111(1):41\u201350.","journal-title":"Cell"},{"issue":"12","key":"1585_CR74","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/nrc2747","volume":"9","author":"S Sahar","year":"2009","unstructured":"Sahar S, Sassone-Corsi P. Metabolism and cancer: the circadian clock connection. Nat Rev Cancer. 2009;9(12):886\u201396.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"1585_CR75","doi-asserted-by":"publisher","first-page":"e3769","DOI":"10.1371\/journal.pone.0003769","volume":"3","author":"J Wang","year":"2008","unstructured":"Wang J, Wang H, Li Z, Wu Q, Lathia JD, McLendon RE, Hjelmeland AB. Rich JN: c-Myc is required for maintenance of glioma cancer stem cells. PLoS ONE. 2008;3(11):e3769.","journal-title":"PLoS ONE"},{"key":"1585_CR76","doi-asserted-by":"publisher","first-page":"685213","DOI":"10.3389\/fimmu.2021.685213","volume":"12","author":"S Ait Ssi","year":"2021","unstructured":"Ait Ssi S, Chraa D, El Azhary K, Sahraoui S, Olive D, Badou A. Prognostic gene expression signature in patients with distinct glioma grades. Front Immunol. 2021;12:685213.","journal-title":"Front Immunol"},{"key":"1585_CR77","doi-asserted-by":"crossref","unstructured":"Zhou DD, Li HL, Liu W, Zhang LP, Zheng Q, Bai J, Hu YQ, Yin CG, Lv SJ, Zhang BG. miR-193a-3p Promotes the Invasion, Migration, and Mesenchymal Transition in Glioma through Regulating BTRC. Biomed Res Int 2021, 2021:8928509.","DOI":"10.1155\/2021\/8928509"},{"issue":"1","key":"1585_CR78","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1515\/tnsci-2021-0004","volume":"12","author":"Y Yang","year":"2021","unstructured":"Yang Y, Wang J, Xu S, Shi F, Shan A. Calumenin contributes to epithelial-mesenchymal transition and predicts poor survival in glioma. Transl Neurosci. 2021;12(1):67\u201375.","journal-title":"Transl Neurosci"},{"issue":"1","key":"1585_CR79","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.tranon.2017.11.007","volume":"11","author":"X Bai","year":"2018","unstructured":"Bai X, Wang J, Huo L, Xie Y, Xie W, Xu G, Wang M. Serine\/Threonine kinase CHEK1-Dependent transcriptional regulation of RAD54L promotes proliferation and Radio Resistance in Glioblastoma. Transl Oncol. 2018;11(1):140\u20136.","journal-title":"Transl Oncol"},{"issue":"1","key":"1585_CR80","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/s13046-019-1358-x","volume":"38","author":"H Cui","year":"2019","unstructured":"Cui H, Wang Q, Lei Z, Feng M, Zhao Z, Wang Y, Wei G. DTL promotes cancer progression by PDCD4 ubiquitin-dependent degradation. J Exp Clin Cancer Res. 2019;38(1):350.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"1585_CR81","doi-asserted-by":"publisher","first-page":"e0191377","DOI":"10.1371\/journal.pone.0191377","volume":"13","author":"MK Hassan","year":"2018","unstructured":"Hassan MK, Kumar D, Naik M, Dixit M. The expression profile and prognostic significance of eukaryotic translation elongation factors in different cancers. PLoS ONE. 2018;13(1):e0191377.","journal-title":"PLoS ONE"},{"key":"1585_CR82","doi-asserted-by":"publisher","first-page":"608082","DOI":"10.3389\/fonc.2020.608082","volume":"10","author":"X Zhang","year":"2020","unstructured":"Zhang X, Wang J, Wang Y, Liu G, Li H, Yu J, Wu R, Liang J, Yu R, Liu X. MELK Inhibition effectively suppresses growth of Glioblastoma and Cancer Stem-Like cells by blocking AKT and FOXM1 pathways. Front Oncol. 2020;10:608082.","journal-title":"Front Oncol"},{"issue":"4","key":"1585_CR83","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1365-2559.1994.tb01353.x","volume":"25","author":"P Korkolopoulou","year":"1994","unstructured":"Korkolopoulou P, Christodoulou P, Lekka-Katsouli I, Kouzelis K, Papanikolaou A, Panayotides I, Mariatos P, Thomas-Tsagli E, Crocker J. Prognostic significance of proliferating cell nuclear antigen (PCNA) expression in gliomas. Histopathology. 1994;25(4):349\u201355.","journal-title":"Histopathology"},{"issue":"15","key":"1585_CR84","doi-asserted-by":"publisher","first-page":"6414","DOI":"10.18632\/oncotarget.2225","volume":"5","author":"AA Patil","year":"2014","unstructured":"Patil AA, Sayal P, Depondt ML, Beveridge RD, Roylance A, Kriplani DH, Myers KN, Cox A, Jellinek D, Fernando M, et al. FANCD2 re-expression is associated with glioma grade and chemical inhibition of the Fanconi Anaemia pathway sensitises gliomas to chemotherapeutic agents. Oncotarget. 2014;5(15):6414\u201324.","journal-title":"Oncotarget"},{"key":"1585_CR85","doi-asserted-by":"publisher","first-page":"825685","DOI":"10.3389\/fgene.2022.825685","volume":"13","author":"J Zhang","year":"2022","unstructured":"Zhang J, Wang D, Chen X, Ji L, Yu M, Guo M, Zhang D, Chen W, Xu F. Upregulation of ferroptosis-related Fanconi Anemia Group D2 is a poor prognostic factor and an Indicator of Tumor Immune Cell Infiltration in Lung Adenocarcinoma. Front Genet. 2022;13:825685.","journal-title":"Front Genet"},{"issue":"Pt 8","key":"1585_CR86","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1093\/brain\/awp153","volume":"132","author":"HC Cheung","year":"2009","unstructured":"Cheung HC, Hai T, Zhu W, Baggerly KA, Tsavachidis S, Krahe R, Cote GJ. Splicing factors PTBP1 and PTBP2 promote proliferation and migration of glioma cell lines. Brain. 2009;132(Pt 8):2277\u201388.","journal-title":"Brain"},{"issue":"2","key":"1585_CR87","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s11060-015-2050-4","volume":"127","author":"D Music","year":"2016","unstructured":"Music D, Dahlrot RH, Hermansen SK, Hjelmborg J, de Stricker K, Hansen S, Kristensen BW. Expression and prognostic value of the WEE1 kinase in gliomas. J Neurooncol. 2016;127(2):381\u20139.","journal-title":"J Neurooncol"},{"issue":"4","key":"1585_CR88","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1615\/CritRevOncog.2022042860","volume":"26","author":"B Valafar","year":"2021","unstructured":"Valafar B, Zaravinos A, Bonavida B. Cross Talk between the circadian clock proteins and TP53 in Cancer and therapeutic significance. Crit Rev Oncog. 2021;26(4):19\u201336.","journal-title":"Crit Rev Oncog"},{"key":"1585_CR89","doi-asserted-by":"publisher","first-page":"589929","DOI":"10.3389\/fimmu.2020.589929","volume":"11","author":"M Dratwa","year":"2020","unstructured":"Dratwa M, Wysoczanska B, Lacina P, Kubik T, Bogunia-Kubik K. TERT-Regulation and roles in Cancer formation. Front Immunol. 2020;11:589929.","journal-title":"Front Immunol"},{"key":"1585_CR90","doi-asserted-by":"publisher","first-page":"711772","DOI":"10.3389\/fphar.2021.711772","volume":"12","author":"S Liu","year":"2021","unstructured":"Liu S, Liu X, Zhang C, Shan W, Qiu X. T-Cell exhaustion status under high and low levels of Hypoxia-Inducible factor 1alpha expression in Glioma. Front Pharmacol. 2021;12:711772.","journal-title":"Front Pharmacol"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01585-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-023-01585-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01585-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T10:04:35Z","timestamp":1688378675000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-023-01585-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,3]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1585"],"URL":"https:\/\/doi.org\/10.1186\/s12920-023-01585-w","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,3]]},"assertion":[{"value":"15 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This manuscript uses publicly available data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"154"}}